VHL LOSS Detail (hg38) (VHL)

Information

Genome

Assembly Position
hg19 chr3:10,182,692-10,193,904 View the variant detail on this assembly version.
hg38 chr3:10,141,008-10,152,220
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Type Database ID Link
Gene MIM 608537 OMIM
HGNC 12687 HGNC
Ensembl ENSG00000134086 Ensembl
NCBI NCBI
Gene Cards Gene Cards
OncoKB OncoKB
Type Database ID Link
Variant TogoVar
COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease Drug EL ET ED CS VO TR Pubmed Links
renal carcinoma Temsirolimus D Predictive Supports Sensitivity/Response Somatic 3 16341243 Detail
renal cell carcinoma Anti-VEGF Monoclonal Antibody B Predictive Does Not Support Sensitivity/Response Somatic 4 28103578 Detail
DisGeNET
[No Data.]
Annotation

Annotations

DescrptionSourceLinks
Preclinical studies linking the efficacy of mTOR inhibitor CCI-779 to VHL loss in vitro and in mouse... CIViC Evidence Detail
A meta-analysis to evaluate the association between the VHL alteration and clinical outcomes in pati... CIViC Evidence Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
VHL
Genome
hg38
Position
chr3:10,141,008-10,152,220
Variant Type
cnv
Variant (CIViC) (CIViC Variant)
LOSS
Transcript 1 (CIViC Variant)
ENST00000256474.2
Variant URL (CIViC Variant)
https://civic.genome.wustl.edu/links/variants/436
Genome browser